Rapid disease pathogen identification a step closer following successful GeneCapture demonstration

FE331E34-70B3-4C72-A79B-9A7B4B0BA7DF

GeneCapture’s unique disposable cartridge design enables rapid multi-pathogen identification directly from samples.

 Soon it could only take an hour to find out what pathogen is making you ill, following the successful demonstration of the world’s first multi-pathogen identification using non-amplified RNA detection by GeneCapture, a company cofounded by researchers at The University of Alabama in Huntsville (UAH), a part of the University of Alabama System.

GeneCapture has licensed a molecular binding technology from UAH and the company’s CAPTURE PLATFORM is on track for commercialization within two years. The GeneCapture team has briefed the Food and Drug Administration (FDA) on its approach and has begun to prepare for the clinical testing required for FDA clearance. It is in discussions with industry leaders for various applications in health care rapid infection detection.

“We made history today—this is the first time an automated rapid pathogen identification has been reported directly from the RNA of the sample, with no modification or amplification of its genetic source, in about an hour,” says GeneCapture CEO and local entrepreneur Peggy Sammon. “We envision a future where finding out why you are sick can be solved almost anywhere, in an hour, and without being chained to a lab.”

Continue reading… “Rapid disease pathogen identification a step closer following successful GeneCapture demonstration”

0